Table 1 Demographic and clinical characteristics of the study population.
From: Minimising radiation exposure in catheter ablation of ventricular arrhythmias
All (n = 52) | Group 1 (n = 25) | Group 2 (n = 27) | |
|---|---|---|---|
Age (years) | 53.4 ± 17.8 | 62 .8 ± 12.5 | 44.7 ± 17.7* |
Male gender [number (%)] | 38 (73.1) | 24 (96%) | 14 (51.9)* |
Body Mass Index (kg/m2) | 25.6 ± 5.2 | 27.1 ± 3.8 | 24.2 ± 6.0** |
Arterial hypertension [number (%)] | 27 (51.9) | 19 (76) | 8 (29.6) |
Hyperlipidemia [number (%)] | 27 (51.9) | 19 (76) | 8 (29.6) |
Diabetes mellitus [number (%)] | 5 (9.6) | 3 (12) | 2 (7.4) |
Ischaemic cardiomyopathy [number (%)] | 19 (36.5) | 19 (76) | 0 |
Non-ischaemic cardiomyopathy [number (%)] | 5 (9.6) | 5 (20) | 0 |
Congenital heart disease [number (%)] | 1 (1.9) | 1 (4) | 0 |
LVEF (%) | 49.5 ± 13.1 | 40.8 ± 10.4 | 57.5 ± 9.7* |
LVEDV (ml) | 154.5 ± 62.4 | 194.7 ± 64.3 | 117.1 ± 28.5* |
RV dysfunction [number (%)] | 5 (9.6) | 4 (16) | 1 (3.7) |
CIED present[number (%)] | 16 (30.7) | 16 (64) | 0 |
AAD non-amiodarone [number (%)] | 34 (65.3) | 21 (84) | 13 (48.1) |
Amiodarone [number (%)] | 9 (17.3) | 7 (28) | 2 (7.4) |
Sustained VT [number (%)] | 15 (28.8) | 10 (40) | 5 (18.5) |
Electrical storm [number (%)] | 8 (15.4) | 8 (32) | 0 |
Tachycardia induced cardiomyopathy [number (%)] | 4 (7.6) | 0 | 4 (14.8) |